• English
    • français
  • Help
  •  | 
  • Contact
  •  | 
  • About
  •  | 
  • Login
  • HAL portal
  •  | 
  • Pages Pro
  • EN
  •  / 
  • FR
View Item 
  •   LillOA Home
  • Liste des unités
  • Lille Neurosciences & Cognition (LilNCog) - U 1172
  • View Item
  •   LillOA Home
  • Liste des unités
  • Lille Neurosciences & Cognition (LilNCog) - U 1172
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Safety reports on the off-label use of ...
  • BibTeX
  • CSV
  • Excel
  • RIS

Document type :
Article dans une revue scientifique: Article de synthèse/Review paper
DOI :
10.1517/14740338.2016.1168397
PMID :
26987987
Permalink :
http://hdl.handle.net/20.500.12210/15854
Title :
Safety reports on the off-label use of baclofen for alcohol-dependence: recommendations to improve causality assessment
Author(s) :
Rolland, Benjamin [Auteur]
Auffret, Marine [Auteur]
Franchitto, Nicolas [Auteur]
Journal title :
Expert opinion on drug safety
Abbreviated title :
Expert Opin. Drug Saf.
Volume number :
15
Pages :
747-751
Publication date :
2016-01-01
ISSN :
1474-0338
English keyword(s) :
baclofen
drug safety
alcohol dependence
Pharmacovigilance
causality
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
BACKGROUND: The off-label use of high-dose baclofen (HDB) for alcohol-dependence has recently spread. However, HDB has been associated with numerous reports of adverse events (AEs). Pharmacovigilance reporting is supposed ...
Show more >
BACKGROUND: The off-label use of high-dose baclofen (HDB) for alcohol-dependence has recently spread. However, HDB has been associated with numerous reports of adverse events (AEs). Pharmacovigilance reporting is supposed to differentiate AEs from adverse drug reactions (ADRs), for which the causality of the drug is determined using validated methods. METHODS: Since 2010, we found 20 publications on baclofen-related AEs in alcohol dependence, in Medline-referenced journals or national pharmacovigilance reports. We focused on whether these reports used causality algorithms, and provided essential elements for determining baclofen causality and excluding the involvement of alcohol and other psychoactive substances or psychotropic drugs. In half of the cases, no causality algorithm was used. Detailed information on baclofen dosing was found in 17 out of 20 (85%) articles, whereas alcohol doses were given only in 10 (50%) publications. Other psychoactive substances and psychotropic drugs were broached in 14 (70%) publications. CONCLUSIONS: future publications reporting suspected HDB-induced ADRs should use validated causality algorithms and provide sufficient amount of contextual information for excluding other potential causes. For HDB, the psychiatric history, and the longitudinal description of alcohol consumptions and associated doses of psychoactive substances or psychotropic medications should be detailed for every reported case.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
CHU Lille
CNRS
Inserm
Université de Lille
Collections :
  • Lille Neurosciences & Cognition (LilNCog) - U 1172
Research team(s) :
Troubles cognitifs dégénératifs et vasculaires
Submission date :
2019-11-27T13:01:47Z
Université de Lille

Mentions légales
Université de Lille © 2017